SCHEMBL4124093

SCHEMBL4124093

C/C(C=O)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
ALOX15 P16050 4/20 0.52
TSHR P16473 4/20 0.52
TDP1 Q9NUW8 3/20 0.52
RECQL P46063 2/20 0.52
HSD17B10 Q99714 2/20 0.52
PTGS1 P23219 2/20 0.50
MAPT P10636 4/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 3/20 0.39
NR1I2 O75469 1/20 0.39
PGR P06401 1/20 0.39
CYP3A4 P08684 2/20 0.35
TRPV1 Q8NER1 1/20 0.35
TP53 P04637 1/20 0.35
APP P05067 1/20 0.35
SNCA P37840 1/20 0.35
NR2E1 Q9Y466 1/20 0.35
HIF1A Q16665 1/20 0.32
GMNN O75496 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13903775 1.00 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL13903782 1.00 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL4124094 1.00 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL21382193 0.95 ALDH1A1 (0.52) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL13903766 0.93 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL13903777 0.93 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL2616645 0.93 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL5074195 0.93 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL2832986 0.93 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL
SCHEMBL17366592 0.93 ALDH1A1 (0.58) ALDH1A1ALOX15TSHRTDP1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12599615-B2 Use of carotenoids in the treatment of senescence-related diseases GAT THERAPEUTICS, S.L. (ES) 2026-04-14 US disclosed
EP-4218746-A1 USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES Gat Therapeutics S.L. (ES) 2023-08-02 EP disclosed
EP-4144338-A2 USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES ALGAKTIV, S.L. (ES) 2023-03-08 EP disclosed
CN-115715804-A Use of carotenoids in the treatment of age-related disorders 阿尔加克蒂夫有限公司 2023-02-28 CN disclosed
US-20220395515-A1 USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES ALGAKTIV, S.L. (ES) 2022-12-15 US disclosed
US-20220152062-A1 USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES GAT THERAPEUTICS, S.L. (ES) 2022-05-19 US disclosed
EP-3705109-A1 CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES Greenaltech, S.L. (ES) 2020-09-09 EP disclosed
US-20090069417-A1 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS LY CORED LTD. (IL) 2009-03-12 US disclosed
US-20090069417-A1 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS LY CORED LTD. (IL) 2009-03-12 US disclosed
US-20090069417-A1 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS LY CORED LTD. (IL) 2009-03-12 US disclosed
EP-1937288-A2 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS Lycored Ltd. (IL) 2008-07-02 EP disclosed
WO-2007043046-A2 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS LYCORED LTD. (IL) 2007-04-19 WO disclosed
WO-2007043046-A2 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS LYCORED LTD. (IL) 2007-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220152062-A1 USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES BCL2, BCL2A1, BCL2L1 ALDH1A1 3785/4885ALOX15 597/4885TSHR 3483/4885
US-20220395515-A1 USE OF CAROTENOIDS IN THE TREATMENT OF SENESCENCE-RELATED DISEASES BCL2, BCL2A1, BCL2L1 ALDH1A1 3785/4885ALOX15 597/4885TSHR 3483/4885
US-12599615-B2 Use of carotenoids in the treatment of senescence-related diseases MCL1, BCLAF1, BCL2A1 ALDH1A1 1904/4885ALOX15 1324/4885TSHR 4119/4885
US-20090069417-A1 CAROTENOID OXIDATION PRODUCTS AS CHEMOPREVENTIVE AND CHEMOTHERAPEUTIC AGENTS DOHH, BBOX1, TXN2 ALDH1A1 27/4885ALOX15 65/4885TSHR 3174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.